Unknown

Dataset Information

0

Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity.


ABSTRACT: Medroxyprogesterone acetate (MPA) is one of the most widely used contraceptives in the world. Epidemiologic studies have uncovered a possible link between the use of MPA and an increased risk of HIV-1 transmission. However, the understanding of the mechanism is still limited. Our previous publication demonstrated that the lysosomal activity in human vaginal epithelial cells attenuated the trafficking of viral particles during HIV-1 transcytosis. In this study, we show that treating human primary cervical epithelial cells with MPA led to a reduction in lysosomal activity. This reduction caused an increase in the intracellular HIV-1 accumulation and, consequently, an increase in viral release. Our study uncovers a novel mechanism by which MPA enhances HIV-1 release in primary cervical epithelial cells, thus providing vital information for HIV intervention and prevention.

SUBMITTER: Jia X 

PROVIDER: S-EPMC8465616 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2008-02-06 | GSE10392 | GEO
2022-04-29 | GSE183513 | GEO
| S-EPMC7245365 | biostudies-literature
| S-EPMC5823982 | biostudies-literature
| S-EPMC6214972 | biostudies-literature
| S-EPMC8636475 | biostudies-literature
| S-EPMC4172039 | biostudies-literature
| S-EPMC3347486 | biostudies-literature
| S-EPMC7337252 | biostudies-literature
| PRJNA761106 | ENA